Two cases with dysferlinopathy;Iki olgu nedeniyle disferlinopati

Turk Noroloji Dergisi

Volumn 17, Issue 1, 2011, Pages 45-50

  Eryaflar, Gaye ^a   Seçil, Yaprak ^a   Beckmann, Yeflim ^a   Kendir, Ayflen Inceoǧlu ^a   Gulden Diniz A ^b   Bafloǧlu, Mustafa ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Dr Behcet Uz Child Disease and Pediatric Surgery Training and Research Hospital   (Turkey)

Author keywords

Dysferlinopathy; Limb girdle muscular dystrophy; Miyoshi myopathy; Type 2B

Indexed keywords

DYSFERLIN;

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DYSFERLINOPATHY; GENE MUTATION; HUMAN; HUMAN TISSUE; LIMB GIRDLE MUSCULAR DYSTROPHY; MIYOSHI MYOPATHY; MUSCLE BIOPSY; PHENOTYPE; RARE DISEASE;

EID: 79957592009     PISSN: 1301062X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bonnemann CG. Limb Girdle muscular dystrophies: an overview. J Child Neurol 1999;14:31-3.
2. Carpenter S, Karpati G. Pathology of Skeletal Muscle. New York: Oxford University Press, 2001:167.
3. Illarioshkin SN, Ivanova-Smolenskaya IA, Tanaka H, Vereshchagin NV, Markova ED, Poleshchuk VV, et al. Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy. Brain 1996;119:1895-909.
4. Erazo R, Henríquez A. Dysferlinopathy LGMD2B in children: description of 3 cases. Neuromuscul Disord 2007;17:788.
5. Kramerova I, Beckmann J. Molecular and cellular basis of calpainopathy (limb-girdle muscular dystrophy type 2A). Biochimica et Biophysica Acta 2007;1772:128-44.
6. Anderson LV, Harison RM. Secondary reduction in calpain 3 expression in patients with limb-girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 2000;10:553-9.
7. Crosbier RH, Heighway J. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 1997;272:31221-4.
8. Kurihara T. Different phenotypes in dysferlinopathy. Intern Med 2002;41:505-6.
9. Suzuki N, Aoki M. Novel dysferlin mutations and characteristic muscle atrophy in late onset miyoshi myopathy. Muscle Nerve 2004;29:721-3.
10. Han R, Campbell KP. Dysferlin and muscle membrane repair. Curr Opin Cell Biol 2007;19:409-16.
11. Linssen WH. Genetic heterogeneity in miyoshi-type distal muscular dystrophy. Neuromuscul Disord 1998;8:317-20.
12. Barohn RJ, Miller RG. Autosomal recessive distal dystrophy. Neurology 1991;41:1365-70.
13. Silver E, Argov Z. Dysferlinopathy in the Jews of Caucasus: a frequent mutation in the dysferlin gene. Neuromuscular Disord 2007;17:950-4.
14. Katz JS, Rando TA. Late onset distal muscular dystrophy affecting the posterior calves. Muscle Nerve 2003;28:443-8.
15. Confalonieri P, Oliva L. Muscle inflammation and MHC class 1 up regulation in muscular dystrophy with lack of dysferlin an immunopathological study. J Neuroimmunol 2003;142:130-6.
16. Argov Z, Sadeh M. Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features. Brain 2000;123:1229-37.
17. Betz RC, Schoser BG. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-9.
18. Miyoshi K, Kawai H, Iwasa M, Kusaka K, Nishino H. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy: seventeen cases in eight families, including an autopsied case. Brain 1986;109:31-54.
19. Chae J. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-55.
20. Weller B. Myopathy with trabecular muscle fibers. Neuromuscul Disord 1999;9:208-14.
21. Murakami N, Sakuta R. Early onset distal muscular dystrophy with normal dysferlin expression. Brain Dev 2005;27:589-91.
22. Aoki M, Liu J. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology 2001;57:271-8.
23. Cupler EJ, Bohlega S, Hessler R, McLean D, Stigsby B, Ahmad J. Miyoshi myopathy in Saudi Arabia: clinical, electrophysiological, histopathological and radiological features. Neuromuscul Disord 1998;8:321-6.
24. Celik M, Ertasoglu H. Phenotypic variation in dysferlinopathy. Nörolojik Bilimler Dergisi 2009;26:106-11.
25. Cenacchi G, Fanin M. Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol 2005;58:190-5.
26. Kawabe K, Goto K. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and miyoshi myopathy. Eur J Neurol 2004;11:657-61.
27. Klinge L, Dean AF. Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord 2008;18:288-90.